Even if we did not measure those alternative PRMs in the scope of our study, our results suggest that they might still be able to increase lectin pathway activation, resulting in increased levels of MASP-1/C1-INH complex and C4d in COVID-19 patients. Here, MASP1 is linked to COVID-19.